Political Influence Hinders FDA Integrity, Former Commissioner Warns

Mar 20, 2026, 2:18 AM

Hover over text to view sources

Concerns about political pressure affecting the Food and Drug Administration (FDA) during the Trump administration have intensified, with former commissioners warning that such influence poses a serious risk to the agency's credibility. This scrutiny arises particularly in light of the FDA's decisions related to the COVID-19 pandemic and vaccine approvals.

Seven former FDA commissioners recently criticized the Trump administration for undermining the FDA's credibility, particularly as it prepares to assess clinical trial data for COVID-19 vaccines. In their opinion piece published in The Washington Post, they highlighted the importance of maintaining public trust in the FDA, noting that nearly 42% of Americans do not trust the agency's decision-making, with 78% expressing concerns that vaccine approvals may be rushed due to political interference.

Former FDA Commissioner Scott Gottlieb emphasized that political influence can prolong public health crises and erode trust in federal oversight of medicine and food safety. He pointed out that while FDA staff are committed to scientific rigor, the perception of political meddling can have detrimental effects on public confidence in the agency's decisions regarding drugs and vaccines.

The influence of the Trump administration on the FDA's actions has been particularly evident in the issuance of Emergency Use Authorizations (EUAs). Reports have surfaced indicating that President Trump pressured the FDA to authorize hydroxychloroquine for COVID-19 treatment, despite a lack of quality evidence supporting its safety and efficacy. Senator Patty Murray (D-WA) voiced her concerns, urging the FDA to shield its experts from political pressures, as any failure to do so could jeopardize public health and safety.

The urgency surrounding the COVID-19 pandemic has led to increased scrutiny of the FDA's decision-making processes. Critics argue that the agency's ability to operate independently is crucial for ensuring that products authorized for public use are based on sound scientific evidence rather than political expediency. The former commissioners collectively asserted that any political intrusion into the FDA's processes could result in adverse health outcomes for the public, as well as a deterioration of the agency's foundational role in safeguarding public health.

As the landscape of regulatory oversight changes, the current administration's approach to the FDA is expected to evolve. With Secretary of Health and Human Services Robert F. Kennedy Jr taking a more active role, there are concerns that his skepticism toward certain medical practices, including vaccines, could further complicate the FDA's mission. Kennedy's past statements on vaccine safety and his commitment to reevaluating FDA's regulatory framework have raised alarms among public health advocates who worry about a shift away from evidence-based policy making.

In conclusion, while the FDA's commitment to public health remains strong, the potential for political interference under the Trump administration raises significant concerns. The need for transparency and independence in the FDA's processes has never been more critical to maintain public trust, especially in the face of ongoing health crises like the COVID-19 pandemic. Ensuring that scientific integrity guides the FDA's decisions will be essential for protecting public health and restoring confidence in the agency's authority and effectiveness in the future.

Senate Democrats Propose Major Health Insurance Overhaul Following Trump Era Setbacks

In response to setbacks during the Trump administration, Senate Democrats are unveiling plans to overhaul health insurance, focusing on Medicaid and other critical programs. The proposed changes aim to address challenges faced by millions of Americans who rely on these services, emphasizing equity and accessibility.

Democratic Health Leaders Warn of ACA Rule's Impact on Coverage Costs

Democratic health leaders are voicing strong opposition to a proposed rule by the Trump Administration that could significantly increase out-of-pocket costs and reduce health coverage for millions of Americans. They argue that the rule undermines the Affordable Care Act, potentially leading to higher premiums and deductibles while also eroding essential consumer protections.

Newsom Challenges Trump and RFK Jr. on Public Health Policies

California Governor Gavin Newsom is asserting his leadership in public health by opposing the Trump administration's policies, particularly those led by Health and Human Services Secretary Robert F. Kennedy Jr Newsom's initiatives include the formation of the West Coast Health Alliance and modernizing the state’s public health system to prioritize science-based guidelines.

Trump's Vaccine Politics: A Stubborn Legacy

Former President Donald Trump remains deeply intertwined in vaccine politics, causing friction within the GOP and public health domains. His administration's Operation Warp Speed successfully developed COVID-19 vaccines, yet his ongoing rhetoric complicates the national vaccination strategy and creates challenges for public health officials.

US Government Urges Caution for Americans Traveling in the Middle East

The US government has issued urgent travel advisories for Americans in the Middle East, advising them to leave due to escalating safety risks. With flight operations affected, the State Department is facilitating assistance for citizens amidst ongoing military actions.